Xycrobe Therapeutics
La Jolla
About Xycrobe Therapeutics
Xycrobe Therapeutics is an early-stage biotechnology company that aims to leverage an extensive amount of data being generated from human microbiome research to develop novel therapies for clinical applications. The company develops innovations that take advantage of the nature of microbes by turning it into vehicles for the delivery of biotherapeutics. The company's goal is to create better solutions for clinical indications, focusing on inflammatory skin diseases.
Company Facts
- Operating status: Closed
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Total funding: $200.0K
- Funding stage: M&A
- Last round: Seed (Jan 2015)
- Website: xycrobe.com
Industries & Categories
Biotechnology, Health Care, Therapeutics, Wellness
Social Profiles
Canonical: https://fsome.com/organization/xycrobe-therapeutics-1375930 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.